is tirzepatide a glp-1 or 2 Unveiling Tirzepatide's Therapeutic Spectrum: Dual GIP/GLP-1 Agonist Targeting Metabolic, Neurological, and Cardiovascular Health Who Qualifies for Tirzepatide Medical

Its an optic neuropathy because the optic nerve at the back of the eye is damaged

Patients who remain at lower doses (2.55 mg) due to side effect concerns may not achieve optimal therapeutic benefit

On tirzepatide, avoiding high-glycemic carbohydrates becomes even more important

Both Tirzepatide and Semaglutide are administered via weekly subcutaneous injections and require careful dose titration to minimize side effects and optimize efficacy

What youll learn: Some people lose hair while taking tirzepatide, but it usually isnt caused by the medication itself, but by how your body reacts to weight loss

It has also been named by Evaluate as one of the most anticipated drugs to be approved in 2022